Imagia

Imagia is leveraging advances in AI to enable accessible personalized care by delivering on the promise of radiomics to predict patient outcomes & detect disease specific markers from imaging data. Imagia provides solutions for biotech and pharma and interventions and diagnostic OEMS. For biotech and pharma, Imagia develops novel deep radiomic biomarkers capable of predicting personalized patient’s disease progression and treatment response.

Deep radiomics biomarkers can instantaneously preview or complement test results weeks before they would be back from the lab. For interventions and diagnostic OEMS, Imagia develops device-specific clinical decisions support systems and real-time AI solutions and it also designs seamless human-machine interfaces augmented with adaptable AI cognitive systems to improve outcomes and reduce procedure time.

Healthcare data is organized for routine clinical access, not for outcome-based investigations; Therefore, Imagia provides an AI-driven structuring solution that unlocks the value of hospital data and allows frictionless access to relevant patient cohorts. Single hospital data-sets are simply not enough to allow AI-driven discovery processes in precision medicine, therefore Imagia lowers the cost of multi-center collaborations by federating AI-friendly cohorts and facilitating access and computational analysis at scale. Traditionally, healthcare data and medical specialties have existed in silos but Imagia accelerates the collective discovery process by removing regulatory concerns, ensuring data traceability for patient privacy and uniting expertise throughout an open ecosystem.

Also, Imagia uses natural language processing and cognitive computing to assemble cohorts without manual curation. Imagia accomplishes this by designing multi-agent systems for computational intelligence that enable machine learning on distributed data-sets.